Status:

RECRUITING

Hand Acceleration Time (HAT) Assessment Before and After Creating an Arteriovenous Fistula (AVF)

Lead Sponsor:

Hospital Universitari de Bellvitge

Conditions:

Arteriovenous Fistula

Vascular Diseases

Eligibility:

All Genders

18+ years

Brief Summary

The main objectives of this observational study are to compare the results of the sonographic parameter hand acceleration time (HAT) measured before and after creating an arteriovenous fistula (AVF) f...

Detailed Description

As the name suggests, hemodialysis access-induced distal ischemia (HAIDI) is an ischemic syndrome affecting the hand in the context of vascular access for hemodialysis. It is caused by the inability o...

Eligibility Criteria

Inclusion

  • Adult patients (≥18 years of age)
  • Both sexes
  • Candidates for AVF creation for hemodialysis
  • Patients who sign the informed consent form

Exclusion

  • Patients deemed unable by the investigators to understand or comply with study-related procedures
  • Patients who refuse to participate in the study

Key Trial Info

Start Date :

June 30 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 28 2025

Estimated Enrollment :

125 Patients enrolled

Trial Details

Trial ID

NCT06187207

Start Date

June 30 2023

End Date

February 28 2025

Last Update

January 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain, 08907